Self-contained training for stroke patients during inpatient rehabilitation
ISRCTN | ISRCTN42633681 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN42633681 |
Secondary identifying numbers | 1-2016 |
- Submission date
- 23/07/2017
- Registration date
- 02/08/2017
- Last edited
- 25/11/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nervous System Diseases
Plain English summary of protocol
Background and study aims
A stroke occurs when the blood supply is cut off to the brain. A majority of stroke patients are affected by an impaired function of the upper extremity (upper body and arms). Numerous studies have indicated that there is a relationship between intensity and amount of training on the one hand and improvement of functions on the other hand. Usually, patients with a severe paresis (muscle weakness) of the upper extremity are treated with the ArmeoSpring exoskeleton during their inpatient rehabilitation. An exoskeleton is a frame that is put on the arm to help support the arm weight and help improve function. The aim of this study is to examine what happens when treatment time with this device is increased without investing additional personnel.
Who can participate?
Stroke patients aged 18 to 85
What does the study involve?
Participants receive 24 training sessions with the exoskeleton over four weeks. This is connected to a computer that offers virtual reality. The degree in which they can move their arm while in the exoskeleton is recorded.
What are the possible benefits and risks of participating?
Participants may benefit from improvements in motor function. The device is safe and has a certificate allowing to use it for patient treatment. There are no known risks.
Where is the study run from?
Kliniken Schmieder (Germany)
When is the study starting and how long is it expected to run for?
February 2016 to February 2017
Who is funding the study?
Kliniken Schmieder (Germany)
Who is the main contact?
Prof. Dr. Joachim Liepert
j.liepert@kliniken-schmieder.de
Contact information
Public
Kliniken Schmieder
Zum Tafelholz 8
Allensbach
78476
Germany
Phone | +49 7533 808 1236 |
---|---|
j.liepert@kliniken-schmieder.de |
Study information
Study design | An interventional study with the ArmeoSpring exoskeleton used as a device for additional self-contained training in evenings and on weekends. The study explores feasibility and acceptance. It is single-centre because it is a pilot study |
---|---|
Primary study design | Interventional |
Secondary study design | Non randomised study |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet. Contact: j.liepert@kliniken-schmieder.de |
Scientific title | Using an upper extremity exoskeleton for semi-autonomous exercise during inpatient neurological rehabilitation- a pilot study |
Study objectives | A self-contained robot-assisted training in addition to conventional inpatient rehabilitation is feasible. |
Ethics approval(s) | University of Constance, 21/04/2016 |
Health condition(s) or problem(s) studied | Stroke patients |
Intervention | Participants receive self-contained training with the Armeo Spring exoskeleton over a period of four weeks with up to 24 treatment sessions. The exoskeleton is connected to a computer that offers a variety of games in a virtual reality environment. For example, patients can paint a room, can grasp objects in a supermarket, can catch balls and so on. The degree to which the patients can move the arm while it is positioned in the exoskeleton is determined. Movements visible on the screen are adjusted to this individual level of performance. There is no follow up. |
Intervention type | Device |
Pharmaceutical study type(s) | |
Phase | |
Drug / device / biological / vaccine name(s) | |
Primary outcome measure | Feasibility (recording of side effects or adverse events) is measured using a structured interview once a week during the 4 weeks. Patients and supervisors are interviewed after the first, second, third and fourth week. |
Secondary outcome measures | Acceptance is measured using the visual analogue scale at the end of the treatment period (after 4 weeks) Motor function is measured using Wolf Motor Function Test at baseline and after 4 weeks of additional therapy. |
Overall study start date | 02/02/2016 |
Completion date | 08/02/2017 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Upper age limit | 85 Years |
Sex | Both |
Target number of participants | 10 |
Total final enrolment | 10 |
Key inclusion criteria | 1. Treatment in a neurological rehabilitation hospital for > 4 weeks 2. Stroke patients 3. Severe upper limb paresis 4. Ability to understand instructions and make own decisions 5. Aged 18-85 years old |
Key exclusion criteria | 1. Unwillingness to participate 2. Inability to understand the instructions |
Date of first enrolment | 02/05/2016 |
Date of final enrolment | 06/01/2017 |
Locations
Countries of recruitment
- Germany
Study participating centre
Allensbach
78476
Germany
Sponsor information
Hospital/treatment centre
Zum Tafelholz 8
Allensbach
78476
Germany
https://ror.org/04bkje958 |
Funders
Funder type
Hospital/treatment centre
No information available
Results and Publications
Intention to publish date | 12/08/2017 |
---|---|
Individual participant data (IPD) Intention to share | Yes |
IPD sharing plan summary | Available on request |
Publication and dissemination plan | We plan to publish data on feasibility, acceptance and changes of motor functions. |
IPD sharing plan | The datasets generated during and/or analysed during the current study are/will be available upon request from Dr. Joachim Liepert; email: j.liepert@kliniken-schmieder.de |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 02/08/2018 | 25/11/2020 | Yes | No |
Editorial Notes
25/11/2020: Publication reference and total final enrolment number added.